Vimarsana
Biggest News Aggregation in the World

Founded Entity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Founded Entity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Founded Entity Today - Breaking & Trending Today

PRTC's Akili Enters Into Merger Agreement | Company Announcement - Vimarsana News

PRTC's Akili Enters Into Merger Agreement | Company Announcement

Investegate announcements from PRTC's Akili Enters Into Merger Agreement

PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection - Vimarsana News

PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection

VE303 is an orally administered, potential first-in-class live biotherapeutic product candidate being developed to prevent recurrence of Clostridioides difficile infection ...

PRTC's Vedanta Begins Phase 3 of VE303 in C. diff | Company Announcement - Vimarsana News

PRTC's Vedanta Begins Phase 3 of VE303 in C. diff | Company Announcement

Investegate announcements from PRTC's Vedanta Begins Phase 3 of VE303 in C. diff

PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments - Vimarsana News

PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments

Denice Torres, J.D., former Board Member of Karuna Therapeutics and accomplished healthcare executive at Johnson & Johnson, Janssen Neuroscience and Eli Lilly, appointed to Seaport Board of...

PureTech Announces Annual Results for Year Ended December 31, 2023 - Vimarsana News

PureTech Announces Annual Results for Year Ended December 31, 2023

Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs,1 launch of two new Founded Entities,2 including a $100 million Series A financing for...